Profile
Florence Alouch is the founder and former Chief Executive Officer of SparingVision SAS, which was founded in 2016.
Currently, she is the Chairman-Supervisory Board at Génomic Vision SA since 2022.
Ms. Alouch holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Universite Paris Cite.
Florence Alouch active positions
| Companies | Position | Start |
|---|---|---|
| GENOMIC VISION | Chairman | 2022-07-10 |
Former positions of Florence Alouch
| Companies | Position | End |
|---|---|---|
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Chief Executive Officer | - |
Training of Florence Alouch
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| Universite Paris Cite | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENOMIC VISION | Health Technology |
| Private companies | 1 |
|---|---|
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Florence Alouch
